HOME >> BIOLOGY >> NEWS
The secret women keep from themselves

CHARLOTTESVILLE, VA (January 11, 2007) -- Do women have a secret so painful that they even keep it from themselves?

According to Dr. Anita H. Clayton of the University of Virginia Health System, the secret exists, and it's big. In an era when so many women are over-achievers with high expectations for almost every area of their lives, too many of them settle for mediocre sex.

Dr. Clayton, who is one of the world's preeminent experts on women's sexuality and a psychiatrist with the University of Virginia Health System, exposes and explores this secret in her new book, Satisfaction: Women, Sex, and the Quest for Intimacy, which is scheduled for release by Ballentine/Random House in mid-January.

Busy, overburdened lives often alter women's and men's libidos. Even when dissatisfied with their sexual lives, few women feel motivated to change, says Clayton.

"Work and family come first. We end up putting sex low on the priority list," Dr. Clayton notes. "Then when our partner initiates sex, it's just another task. I really believe that we as women accept a level of dissatisfaction that we don't need to accept."

Cultural and religious beliefs often place limitations on passion and desire, she adds. After pregnancy, a woman's view of herself as a sexual being may change. Menopause often considered a time of diminished desire can actually be a time of heightened arousal and desire because of more personal freedom and fewer childrearing responsibilities.

Written with Robin Cantor-Cooke, Satisfaction is based on Dr. Clayton's extensive research and clinical experience with thousands of women. The book provides guidance on a variety of topics, including:

  • Why drugs like Viagra, Levitra and Cialis don't work for women;
  • How the four main categories of female sexual dysfunction difficulty with desire, difficulty becoming aroused, difficulty achieving orgasm, and bodily pain during
    '"/>


Contact: Mary Jane Gore
mjgore@virginia.edu
434-924-9241
University of Virginia Health System
11-Jan-2007


Page: 1 2

Related biology news :

1. Secret life of elephant seals not secret anymore!
2. Anthrax bacteriums deadly secrets probed
3. Uncovering the secrets of the deep
4. Natures secrets yield new adhesive material
5. Decoding mushrooms secrets could combat carbon, find better biofuels and safer soils
6. St. Jude study yields secrets of chromosome movement
7. UVa-led team uncovers important secret in gene replication
8. UCR biologists unravel the genetic secrets of black widow spider silk
9. Nature surrenders flowery secrets to international team
10. Scientists identify prions infectious secret
11. Puzzling plankton yield secrets to role in evolution/global photosynthesis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The secret women keep from themselves

(Date:10/22/2014)... Medicine® scientists helps explain how bipolar disorder affects the ... therapies to treat the mental illness. , Scientists ... method recognized with the 2014 Nobel Prize in ... from mice with bipolar-like behaviors. In the synapses (where ... structures with concentrated levels of ANK3 -- the gene ...
(Date:10/22/2014)... , Oct. 20, 2014  Leading identity analyst firm ... half of the world,s population will have a chip-based ... Europe . Asia , ... market accounting for more than 60% of all National ... Acuity,s report  -- "The Global National eID ...
(Date:10/19/2014)... in India over the last 30 years contributed ... growth during that time, according to a new ... Change ., "Energy access is fundamental to development: ... including education, communication, and health," says IIASA researcher ... increased energy access is widely agreed to be ...
Breaking Biology News(10 mins):Bipolar disorder discovery at the nano level 2Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Improved electricity access has little impact on climate change 2
(Date:10/25/2014)... , October 24, 2014 ... Corporation (NASDAQ: CYTR ), Vertex Pharmaceuticals Inc. ... ALXN ), Peregrine Pharmaceuticals Inc. (NASDAQ: ... research on these five companies can be accessed at: ... Thursday, October 23, 2014, ended on a positive note ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis ... specialty pharmaceutical company, and Rhythm, a biopharmaceutical company, today ... to acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., ... for the treatment of diabetic gastroparesis and other GI ... successful Phase 2 trial of relamorelin for the treatment ...
(Date:10/22/2014)... WriteResult, LLC – a premier provider of ... a team of researchers from Yale University’s School of ... to provide electronic questionnaire data collection through use of ... in May, aims to evaluate the impact of a ... and participation in urban agriculture to impact their consumption ...
(Date:10/22/2014)... ROCKVILLE, Md. , Oct. 22, 2014   ... company developing novel pathogen-specific therapies for serious infections and ... Office has issued a Notice of Allowance for a ... product in its C. difficile program, SYN-004. This ... to SYN-004 in the U.S. and adds to the ...
Breaking Biology Technology:Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4
Cached News: